01/23/2025
5:38 PM | GAGNON SECURITIES LLC (Filed by)
Profound Medical (Subject)
| Form SCHEDULE 13G/A | |
01/08/2025
6:45 AM | Profound Medical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
7:30 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024
4:18 PM | Profound Medical (Filer)
| Form SUPPL | |
12/06/2024
4:19 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024
2:10 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
4:16 PM | Profound Medical (Filer)
| Form SUPPL | |
12/05/2024
4:21 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
4:01 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024
6:45 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024
7:00 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for PROF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
3:27 PM | GAGNON SECURITIES LLC (Filed by)
Profound Medical (Subject)
| Form SC 13G/A | |
11/12/2024
12:52 PM | Goodman Abbey (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
6:15 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2024
3:45 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024
3:30 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
8:42 AM | LETKO, BROSSEAU & ASSOCIATES INC (Filed by)
Profound Medical (Subject)
| Form SCHEDULE 13G/A | |
09/23/2024
3:42 PM | Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
7:15 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024
5:02 AM | Profound Medical (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/04/2024
4:02 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024
11:15 AM | Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
12:31 PM | Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
6:50 AM | BDC CAPITAL INC. (Filed by)
Profound Medical (Subject)
| Form SC 13G/A | |
07/18/2024
3:45 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
11:15 PM | Profound Medical (Filer)
| Form EFFECT | |
07/10/2024
5:37 PM | Profound Medical (Filer)
| Form F-10/A | |
06/14/2024
4:23 PM | Profound Medical (Subject)
| Form F-X
Appointment of agent for service of process and undertaking | |
06/03/2024
3:30 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
8:30 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
3:30 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
3:20 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
6:55 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
11:31 AM | Goodman Abbey (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:42 PM | Profound Medical (Filer)
| Form 40-F
Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d) | |
02/27/2024
7:00 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Free PROF Stock Alerts